Childhood absence epilepsy Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

2 events

Jul 2024A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

UCB Biopharma SRL — PHASE3

TrialRECRUITING

Jul 2021A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

UCB Biopharma SRL — PHASE3

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Childhood absence epilepsy.
Check the disease page for updates →

Clinical Trial Landscape

2 active trials

2Phase 3

2Total recruiting

Search clinical trials for Childhood absence epilepsy →

Recent News & Research

No recent news articles indexed yet for Childhood absence epilepsy.
Search PubMed for Childhood absence epilepsy →

Browse all Childhood absence epilepsy news →

Specialist Network

Top 6 by expertise

Tracy A. Glauser, MD, M.D

Children's Hospital Medical Center, Cincinnati

📍 CINCINNATI, OH

Score 221 trial

Avital Cnaan, PhD

Children's National Research Institute

Score 201 trial

Eric H Kossoff, MD, M.D

Johns Hopkins University

📍 BALTIMORE, MD

Score 166 trials

Jennifer Guo, MS

Yale University

Score 71 trial

Peter Adamson, MD

Children's Hospital of Philadelphia

Score 61 trial

R. Todd Constable, PhD

Yale University

Score 41 trial

View all Childhood absence epilepsy specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰